Ian G Cannell

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Metastatic Breast Cancer

Top Venues

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mariam-Eleni Oraiopoulou, Dominique-Laurent Couturier, Ellie V Bunce, Ian G Cannell, Paul W Sweeney, Huw Naylor, Monika A Golinska, Gregory James Hannon, Vangelis Sakkalis, Sarah E Bohndiek
The in vitro dynamics of pseudo-vascular network formation. British journal of cancer 131 (3) (2024)
Mariam-Eleni Oraiopoulou, Dominique-Laurent Couturier, Ellie V Bunce, Ian G Cannell, Paul W Sweeney, Huw Naylor, Monika A Golinska, Gregory James Hannon, Vangelis Sakkalis, Sarah E Bohndiek
The in vitro dynamics of pseudo-vascular network formation. British journal of cancer 131 (3) (2024)
Mariam-Eleni Oraiopoulou, Dominique-Laurent Couturier, Ellie V Bunce, Ian G Cannell, Paul W Sweeney, Huw Naylor, Monika A Golinska, Gregory James Hannon, Vangelis Sakkalis, Sarah E Bohndiek
The in vitro dynamics of pseudo-vascular network formation. British journal of cancer 131 (3) (2024)
Mariam-Eleni Oraiopoulou, Dominique-Laurent Couturier, Ellie V Bunce, Ian G Cannell, Paul W Sweeney, Huw Naylor, Monika A Golinska, Gregory James Hannon, Vangelis Sakkalis, Sarah E Bohndiek
The in vitro dynamics of pseudo-vascular network formation. British journal of cancer (2024)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)
Sophia A Wild, Ian G Cannell, Ashley Nicholls, Katarzyna Kania, Dario Bressan, null null, Gregory James Hannon, Kirsty Sawicka
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. eLife 11 (2022)